Journal
CELLULAR SIGNALLING
Volume 31, Issue -, Pages 1-14Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2016.12.005
Keywords
Huntington's Disease; Transcription; EGF; TGF-beta; SMAD; Kinase signalling
Categories
Funding
- Wellcome Trust [089640/Z/09/Z]
- European Huntington's Disease Network Seedfund [579]
- Medical Research Council [G0801418, MR/L010305/1] Funding Source: researchfish
- Wellcome Trust [089640/Z/09/Z] Funding Source: Wellcome Trust
- MRC [MR/L023784/2, MR/L023784/1, G0801418] Funding Source: UKRI
Ask authors/readers for more resources
Transcriptional dysregulation is observable in multiple animal and cell models of Huntington's disease, as well as in human blood and post-mortem caudate. This contributes to HD pathogenesis, although the exact mechanism by which this occurs is unknown. We therefore utilised a dynamic model in order to determine the differential effect of growth factor stimulation on gene expression, to highlight potential alterations in kinase signalling pathways that may be in part responsible for the transcriptional dysregulation observed in HD, and which may reveal new therapeutic targets. We demonstrate that cells expressing mutant huntingtin have a dysregulated transcriptional response to epidermal growth factor stimulation, and identify the transforming growth factor-beta pathway as a novel signalling pathway of interest that may regulate the expression of the Huntingtin (HIT) gene itself. The dysregulation of HTT expression may contribute to the altered transcriptional phenotype observed in HD. (C) 2016 The Authors. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available